BLPH - Bellerophon Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 7/13/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) -0.78
52-Week Change 337.91%
S&P500 52-Week Change 35.66%
52 Week High 326.00
52 Week Low 33.19
50-Day Moving Average 313.14
200-Day Moving Average 310.36

Share Statistics

Avg Vol (3 month) 3313.85k
Avg Vol (10 day) 3171.38k
Shares Outstanding 59.5M
Float 4.24M
% Held by Insiders 111.65%
% Held by Institutions 135.58%
Shares Short (Jun 29, 2020) 4476.62k
Short Ratio (Jun 29, 2020) 41.93
Short % of Float (Jun 29, 2020) 46.33%
Short % of Shares Outstanding (Jun 29, 2020) 45.02%
Shares Short (prior month May 28, 2020) 4110.22k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Feb 09, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-59.25%
Return on Equity (ttm)-280.17%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.93M
Net Income Avi to Common (ttm)-17.44M
Diluted EPS (ttm)-3.83
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.6M
Total Cash Per Share (mrq)1.4
Total Debt (mrq)2.16M
Total Debt/Equity (mrq)100.56
Current Ratio (mrq)1.34
Book Value Per Share (mrq)0.44

Cash Flow Statement

Operating Cash Flow (ttm)-14.93M
Levered Free Cash Flow (ttm)-8.86M